Ionis Pharmaceuticals | IONS - 贸易债权人



金融业
股票价格
USD
资产
USD 2.99B
现金及等价物
USD 350.07M
销售成本
USD 2.74M
流动资产
USD 2.49B
流动负债
USD 315.64M
债务
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
员工
1.07K
EPS每股收益
USD -0.69
股本和储备
USD 439.74M
销售毛利
USD 265M
债务利息支出
USD 18M
利息收入
USD -0.66
贷款资金
USD 1.91B
市值
USD 8.46B
净收入
USD -114.65M
营业费用
USD 370.24M
营业利润
USD -102.29M
普通股股本
USD 165.64M
PE价格收益
396.15
税前利润
USD -114M
销售收入
USD 268M
销售和管理费用
USD 130.08M
股票
USD 50.83M
贸易债权人
USD 47.7M
应收帐款人
USD 58.85M


贸易债权人 更改 日
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Arrowhead Research USD 27.78M 2.97M 2026-06
Astellas Pharma JPY 192.29B 7.47B 2026-06
BioCryst Pharmaceuticals USD 11.46M 501K 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Celltrion KRW 88.58B 9.9B 2026-03
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Divis Laboratories Ltd INR 12.11B 1.71B 2026-03
Exelixis USD 39.06M 14.91M 2026-06
Halozyme Therapeutics USD 23.61M 9.51M 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Kangmei Pharma CNY 2.46B 153.5M 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Medical Developments International AUD 4.31M 2.18M 2025-12
Moderna USD 167M 6M 2026-06
Nektar Therapeutics USD 10.03M 744K 2026-03
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.26B 64M 2026-06
Omeros USD 8.84M 4.42M 2025-06
OPKO Health USD 44.18M 3.07M 2026-03
Organigram Holdings CAD 73.14M 2.06M 2026-03
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pfizer USD 4.58B 75M 2026-06
Pharma Mar EUR 38.93M 4.9M 2026-06
PTC Therapeutics USD 40.45M 14.96M 2026-06
Qiagen NV USD 79.08M 785K 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Sartorius EUR 329.1M 16.2M 2026-06
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Tilray USD 114.5M 3.69M 2025-09
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Vertex Pharmaceuticals USD 3.61B 135M 2026-06
Zealand Pharma A/S 171M 175.6M 2026-03
Zz Pientze Pharmaceu CNY 471.72M 14.67M 2026-06